Business
Vaccine Stocks Fall After Fda's Peter Marks Resigns Over Rfk Jr.
By CNBC
"Taking a step back, we view this departure as a significant negative for the BioPharma and Biotech sectors, as FDA's independence rooted in sound scientific rigor is critical for their efficient functioning," analysts at BMO Capital Markets wrote in ...Read more
